(Q40856703)

24 September 2017

title

Perspectives on the statistician's role in cooperative clinical research (English)

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

author name string

N. Breslow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A342084

31 March 2023

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

1 reference

24 September 2017

volume

41

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

326-332

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197801%2941%3A1%3C326%3A%3AAID-CNCR2820410143%3E3.0.CO%3B2-2

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197801%2941%3A1%3C326%3A%3AAID-CNCR2820410143%3E3.0.CO%3B2-2

Minimization: A new method of assigning patients to treatment and control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197801%2941%3A1%3C326%3A%3AAID-CNCR2820410143%3E3.0.CO%3B2-2

Analysis of Survival Data under the Proportional Hazards Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197801%2941%3A1%3C326%3A%3AAID-CNCR2820410143%3E3.0.CO%3B2-2

Report of the scientific meeting on some developments in the methodology of controlled clinical trials in cancer.

21 January 2018

3

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Evidence for immune reactions to neuroblastoma and future possibilities for investigation

31 March 2023

4

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

7

31

2098

Breslow

1971

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Randomized clinical trials. Perspectives on some recent ideas

31 March 2023

9

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

An exponential model relating censored survival data and concomitant information for prostatic cancer patients

31 March 2023

10

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Controlled Studies in Clinical Cancer Research

31 March 2023

11

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

The role of hypothesis testing in clinical trials. Biometrics seminar

31 March 2023

15

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

The treatment of Wilms' tumor. Results of the national Wilms' tumor study

31 March 2023

16

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

31 March 2023

17

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Early human studies with anticancer agents: the question of sample size

31 March 2023

20

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Non-Randomized Controls in Cancer Clinical Trials

31 March 2023

21

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Planning the size and duration of a clinical trial studying the time to some critical event

31 March 2023

22

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

31 March 2023

23

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

The Clinical Trial

25

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

The clinical trial

26

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

The impact of chemotherapy on advanced neuroblastoma. Survival of patients diagnosed in 1956, 1962, and 1966-68 in Children's Cancer Study Group A

31 March 2023

29

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count

31 March 2023

32

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Epidemiological factors and survival experience in 1770 children with acute leukemia. Treated by members of Children's Study Group A between 1957 and 1964

31 March 2023

36

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

31 March 2023

37

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

Predinsome therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients

31 March 2023

41

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

The randomization and stratification of patients to clinical trials

31 March 2023

42

1 reference

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C326::AID-CNCR2820410143%3E3.0.CO;2-2

31 March 2023

Identifiers

10.1002/1097-0142(197801)41:1<326::AID-CNCR2820410143>3.0.CO;2-2

1 reference

24 September 2017

1 reference